Moody's Investors Service assigned its "Aa2" rating to Rochester, Minn.-based Mayo Clinic's proposed $200 million series 2018 revenue bonds. Concurrently, Moody's affirmed its "Aa2" rating on the health system's $3 billion of outstanding debt.
The assignment and affirmation are a result of several factors, including Mayo Clinic's large size, revenue diversification, strong clinical reputation and favorable fundraising capabilities, which lead to a robust balance sheet that generates investment returns.
Moody's acknowledged the health system's upcoming period of elevated capital spending to fund expansion projects.
The outlook is stable, reflecting Moody's expectation that the health system will maintain its operating margins and other balance sheet metrics to support the heightened capital spending.